Early trial tests 'Supercharged' immune cells against skin cancer
Disease control
Recruiting now
This early-stage study is testing whether injecting two types of donor immune cells directly into skin cancer tumors is safe and can help the body fight the cancer. The trial will involve 40 adults with basal cell or squamous cell carcinoma who are already scheduled for surgical …
Phase: EARLY_PHASE1 • Sponsor: Kirsten Johnson • Aim: Disease control
Last updated Mar 19, 2026 14:56 UTC